Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 1,021–1,030 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 1021
- Medicine slug
- misoprostol
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 19
- Source count
- 19
- Agreement rate
- 1
- Recorded readings
90%
- Numeric value
- 90
- Unit
- %
- Source records
- 19
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 19 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9462d969-d3e5-4e7f-b556-bd647ab28c42 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51b0bac5-19e3-4547-ba1f-01494fda7687 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:28a4138c-f302-5109-e063-6394a90a94fa (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2fd197c6-05db-5011-e063-6294a90a585d (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f4d6f06-529c-4b54-908a-0db4c18aff67 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8642b8e4-d1bb-f12a-e053-2a91aa0a14bf (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a46d05a2-5014-40ff-8f1b-9eca1b0aff3a (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4fe14fb-0a43-4c31-9cd6-29eb0d156705 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b07b3dfc-1cb5-484c-be11-8d14c89c794f (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52a82e45-afc5-47d0-a77f-a225609e2f6b (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2396e9c0-3742-69cf-e063-6394a90adb13 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14f73ae3-7d8d-4d10-b668-8bd5adf8032c (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ab12da7-5731-4e06-bf1c-bc3f2e711f12 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b5d0fcb-cc9c-5bb0-e063-6294a90ab1c8 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4668066-3d67-487d-9071-f1e504f66499 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21e20753-4a67-ce4e-e063-6394a90aa598 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c842c35f-6a64-4ecc-95a1-41b6d056047e (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85410e16-d164-4666-9539-778e2b4dd138 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21386aa1-dc51-41c9-8872-dec4c71ebb46 (opens source in a new tab)
Misoprostol label
Version not recorded · Effective date not recorded
The serum protein binding of misoprostol acid is less than 90% and is concentration-independent in the therapeutic range.
Projected row 1022
- Medicine slug
- mitapivat
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
73%
- Numeric value
- 73
- Unit
- %
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ccee896-e313-4c6c-9674-b4746ada0a90 (opens source in a new tab)
Mitapivat label
Version not recorded · Effective date not recorded
The absolute bioavailability after a single dose was approximately 73%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d4e2654-1636-0d01-e063-6394a90af303 (opens source in a new tab)
Mitapivat label
Version not recorded · Effective date not recorded
The absolute bioavailability after a single dose was approximately 73%.
Projected row 1023
- Medicine slug
- mitapivat
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
2.3 hours
- Numeric value
- 2.3
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ccee896-e313-4c6c-9674-b4746ada0a90 (opens source in a new tab)
Mitapivat label
Version not recorded · Effective date not recorded
m carbohydrate, and 150 calories from protein) did not change the exposure (AUC inf ) of mitapivat, but reduced the rate of mitapivat absorption, with a 42% reduction in C max and a delay in t max of 2.3 hours when compared to dosing under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d4e2654-1636-0d01-e063-6394a90af303 (opens source in a new tab)
Mitapivat label
Version not recorded · Effective date not recorded
m carbohydrate, and 150 calories from protein) did not change the exposure (AUC inf ) of mitapivat, but reduced the rate of mitapivat absorption, with a 42% reduction in C max and a delay in t max of 2.3 hours when compared to dosing under fasted conditions.
Projected row 1024
- Medicine slug
- mitapivat
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
42.5 L
- Numeric value
- 42.5
- Unit
- L
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ccee896-e313-4c6c-9674-b4746ada0a90 (opens source in a new tab)
Mitapivat label
Version not recorded · Effective date not recorded
The mean volume of distribution at steady state (Vss) was 42.5 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d4e2654-1636-0d01-e063-6394a90af303 (opens source in a new tab)
Mitapivat label
Version not recorded · Effective date not recorded
The mean volume of distribution at steady state (V ss ) was 42.5 L.
Projected row 1025
- Medicine slug
- mitotane
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
18 to 159 days
- Numeric value
- Not parsed
- Unit
- Not recorded
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4046a224-8832-daa2-e063-6294a90a11d7 (opens source in a new tab)
Mitotane label
Version not recorded · Effective date not recorded
Elimination Following discontinuation of mitotane, the plasma terminal half-life ranges from 18 to 159 days (median 53 days).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0cd76e9-460c-450e-b094-172e636f340a (opens source in a new tab)
Mitotane label
Version not recorded · Effective date not recorded
Elimination Following discontinuation of mitotane, the plasma terminal half-life ranges from 18 to 159 days (median 53 days).
Projected row 1026
- Medicine slug
- mitoxantrone
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 3
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
1,000 L
- Numeric value
- 1,000
- Unit
- L
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1634528a-30c5-4309-acc8-4c0293ae14ae (opens source in a new tab)
Mitoxantrone label
Version not recorded · Effective date not recorded
Distribution to tissues is extensive: steady-state volume of distribution exceeds 1,000 L/m 2 .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:accf9569-4b57-4e83-a7db-4e890a75d1ba (opens source in a new tab)
Mitoxantrone label
Version not recorded · Effective date not recorded
Distribution to tissues is extensive: steady-state volume of distribution exceeds 1,000 L/m 2 .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fcb8ef8a-f770-4416-8fc5-fa01d98c8eee (opens source in a new tab)
Mitoxantrone label
Version not recorded · Effective date not recorded
Distribution to tissues is extensive: steady-state volume of distribution exceeds 1,000 L/m 2 .
Projected row 1027
- Medicine slug
- modafinil
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 34
- Source count
- 28
- Agreement rate
- 1
- Recorded readings
15 hours
- Numeric value
- 15
- Unit
- hours
- Source records
- 28
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 28 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b8496fe-b647-4ce6-aeef-71245712e46f (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4a27496-0f5a-4ea8-b48c-72fcb323dc8f (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98e54b10-8ae0-7c43-e053-2a95a90ae8bb (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0c43046-fc86-4b62-bd0f-704a6894625d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ccf7836d-c131-4e7d-a339-fbf99fe7f449 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4790bbe9-d753-1067-02ee-9536011650d9 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b63aac6-4385-44a3-8390-cdbb0b4b5fe0 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cad4201c-133c-4a61-9d93-3c5e51695430 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f733d7f-1213-4534-9433-0eb99a5abc2c (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41f9ddbd-5228-4f0c-b0aa-2056af79a21e (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4aa3bdad-163f-fda1-e063-6394a90ae1d8 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d97684d7-c236-451e-99bd-b8df4bf36643 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f3b0bd2-72a3-411f-aeec-b533373f1a97 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e16c26ad-7bc2-d155-3a5d-da83ad6492c8 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b8d1c32-dac9-50e6-e063-6394a90aa5a5 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:013450dd-cd42-46c7-98d6-9a2925761978 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f51ca007-3955-4540-a88a-0ddae8d8e8ab (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a7ab52b-db31-4774-a06a-b11f2bb60662 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a309416-bd6a-45b1-982f-b689b097453d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60ec6e2a-2576-498f-9a8c-fddc53d4a44c (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:944daf47-49a6-93ca-e348-4a0f1b6d937e (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1ff7c6d-df04-48dd-a971-454d38e7d997 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:963aa6be-5aed-4865-b375-8c2c3102e7bc (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0391f182-1958-9fef-a944-53b229ce99e7 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d4c6858-5b2f-f216-e063-6394a90aad5d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63604fef-0b80-40ce-8dbf-3384f1aee395 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd1454b3-8599-4dfa-aaf7-b8a3ebe85acd (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:928a3ab6-b53c-4924-882c-9f2f49aba0f1 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
The effective elimination half-life of modafinil after multiple doses is about 15 hours.
Projected row 1028
- Medicine slug
- modafinil
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 34
- Source count
- 34
- Agreement rate
- 1
- Recorded readings
60%
- Numeric value
- 60
- Unit
- %
- Source records
- 34
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 34 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b8496fe-b647-4ce6-aeef-71245712e46f (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c9c4e61-517c-a9d2-e063-6394a90a58c7 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4a27496-0f5a-4ea8-b48c-72fcb323dc8f (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98e54b10-8ae0-7c43-e053-2a95a90ae8bb (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0c43046-fc86-4b62-bd0f-704a6894625d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ccf7836d-c131-4e7d-a339-fbf99fe7f449 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c332ea93-48d9-4c8a-a1ef-01c27a61350b (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:463bb960-a0b5-4ca4-e063-6294a90a683b (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4790bbe9-d753-1067-02ee-9536011650d9 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b63aac6-4385-44a3-8390-cdbb0b4b5fe0 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cad4201c-133c-4a61-9d93-3c5e51695430 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro, modafinil is moderately bound to plasma protein (~60%, mainly to albumin).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f733d7f-1213-4534-9433-0eb99a5abc2c (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro, modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41f9ddbd-5228-4f0c-b0aa-2056af79a21e (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4aa3bdad-163f-fda1-e063-6394a90ae1d8 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d97684d7-c236-451e-99bd-b8df4bf36643 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f3b0bd2-72a3-411f-aeec-b533373f1a97 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro, modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15739a31-2433-49b5-90ea-b974214f73be (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e16c26ad-7bc2-d155-3a5d-da83ad6492c8 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro, modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b8d1c32-dac9-50e6-e063-6394a90aa5a5 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro, modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:013450dd-cd42-46c7-98d6-9a2925761978 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f51ca007-3955-4540-a88a-0ddae8d8e8ab (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a7ab52b-db31-4774-a06a-b11f2bb60662 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a309416-bd6a-45b1-982f-b689b097453d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro, modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:457662d8-b95c-d3af-e063-6294a90a883e (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60ec6e2a-2576-498f-9a8c-fddc53d4a44c (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro, modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:944daf47-49a6-93ca-e348-4a0f1b6d937e (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bc3cd03-2726-f693-e063-6294a90a7a03 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1ff7c6d-df04-48dd-a971-454d38e7d997 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:963aa6be-5aed-4865-b375-8c2c3102e7bc (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0391f182-1958-9fef-a944-53b229ce99e7 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro, modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d4c6858-5b2f-f216-e063-6394a90aad5d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63604fef-0b80-40ce-8dbf-3384f1aee395 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd1454b3-8599-4dfa-aaf7-b8a3ebe85acd (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro, modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:928a3ab6-b53c-4924-882c-9f2f49aba0f1 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
In human plasma, in vitro , modafinil is moderately bound to plasma protein (approximately 60%), mainly to albumin.
Projected row 1029
- Medicine slug
- modafinil
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 34
- Source count
- 28
- Agreement rate
- 1
- Recorded readings
2 to 4 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 28
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 28 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b8496fe-b647-4ce6-aeef-71245712e46f (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4a27496-0f5a-4ea8-b48c-72fcb323dc8f (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil tablet is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98e54b10-8ae0-7c43-e053-2a95a90ae8bb (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0c43046-fc86-4b62-bd0f-704a6894625d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ccf7836d-c131-4e7d-a339-fbf99fe7f449 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4790bbe9-d753-1067-02ee-9536011650d9 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b63aac6-4385-44a3-8390-cdbb0b4b5fe0 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cad4201c-133c-4a61-9d93-3c5e51695430 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Absorption of modafinil tablets is rapid, with peak plasma concentrations occurring at 2-4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f733d7f-1213-4534-9433-0eb99a5abc2c (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil tablet is readily absorbed after oral administration, with peak plasma concentrations occurring at 2-4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41f9ddbd-5228-4f0c-b0aa-2056af79a21e (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4aa3bdad-163f-fda1-e063-6394a90ae1d8 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d97684d7-c236-451e-99bd-b8df4bf36643 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f3b0bd2-72a3-411f-aeec-b533373f1a97 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2-4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e16c26ad-7bc2-d155-3a5d-da83ad6492c8 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption PROVIGIL is readily absorbed after oral administration, with peak plasma concentrations occurring at 2-4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b8d1c32-dac9-50e6-e063-6394a90aa5a5 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption PROVIGIL is readily absorbed after oral administration, with peak plasma concentrations occurring at 2-4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:013450dd-cd42-46c7-98d6-9a2925761978 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f51ca007-3955-4540-a88a-0ddae8d8e8ab (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a7ab52b-db31-4774-a06a-b11f2bb60662 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil tablet is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a309416-bd6a-45b1-982f-b689b097453d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil tablet is readily absorbed after oral administration, with peak plasma concentrations occurring at 2-4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60ec6e2a-2576-498f-9a8c-fddc53d4a44c (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil tablet is readily absorbed after oral administration, with peak plasma concentrations occurring at 2-4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:944daf47-49a6-93ca-e348-4a0f1b6d937e (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil tablet is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1ff7c6d-df04-48dd-a971-454d38e7d997 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:963aa6be-5aed-4865-b375-8c2c3102e7bc (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0391f182-1958-9fef-a944-53b229ce99e7 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption PROVIGIL is readily absorbed after oral administration, with peak plasma concentrations occurring at 2-4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d4c6858-5b2f-f216-e063-6394a90aad5d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil tablet is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63604fef-0b80-40ce-8dbf-3384f1aee395 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd1454b3-8599-4dfa-aaf7-b8a3ebe85acd (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil tablet is readily absorbed after oral administration, with peak plasma concentrations occurring at 2-4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:928a3ab6-b53c-4924-882c-9f2f49aba0f1 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Absorption Modafinil is readily absorbed after oral administration, with peak plasma concentrations occurring at 2 to 4 hours.
Projected row 1030
- Medicine slug
- modafinil
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 34
- Source count
- 34
- Agreement rate
- 1
- Recorded readings
0.9 L/kg
- Numeric value
- 0.9
- Unit
- L/kg
- Source records
- 34
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 34 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b8496fe-b647-4ce6-aeef-71245712e46f (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c9c4e61-517c-a9d2-e063-6394a90a58c7 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4a27496-0f5a-4ea8-b48c-72fcb323dc8f (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil tablets have an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98e54b10-8ae0-7c43-e053-2a95a90ae8bb (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0c43046-fc86-4b62-bd0f-704a6894625d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ccf7836d-c131-4e7d-a339-fbf99fe7f449 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c332ea93-48d9-4c8a-a1ef-01c27a61350b (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:463bb960-a0b5-4ca4-e063-6294a90a683b (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4790bbe9-d753-1067-02ee-9536011650d9 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b63aac6-4385-44a3-8390-cdbb0b4b5fe0 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cad4201c-133c-4a61-9d93-3c5e51695430 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil is well distributed in body tissue with an apparent volume of distribution (~0.9 L/kg) larger than the volume of total body water (0.6 L/kg).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f733d7f-1213-4534-9433-0eb99a5abc2c (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil tablets has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41f9ddbd-5228-4f0c-b0aa-2056af79a21e (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4aa3bdad-163f-fda1-e063-6394a90ae1d8 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d97684d7-c236-451e-99bd-b8df4bf36643 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f3b0bd2-72a3-411f-aeec-b533373f1a97 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15739a31-2433-49b5-90ea-b974214f73be (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e16c26ad-7bc2-d155-3a5d-da83ad6492c8 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution PROVIGIL has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b8d1c32-dac9-50e6-e063-6394a90aa5a5 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution PROVIGIL has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:013450dd-cd42-46c7-98d6-9a2925761978 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f51ca007-3955-4540-a88a-0ddae8d8e8ab (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a7ab52b-db31-4774-a06a-b11f2bb60662 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil tablets have an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a309416-bd6a-45b1-982f-b689b097453d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil tablets has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:457662d8-b95c-d3af-e063-6294a90a883e (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60ec6e2a-2576-498f-9a8c-fddc53d4a44c (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil tablets has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:944daf47-49a6-93ca-e348-4a0f1b6d937e (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil tablets have an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bc3cd03-2726-f693-e063-6294a90a7a03 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1ff7c6d-df04-48dd-a971-454d38e7d997 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:963aa6be-5aed-4865-b375-8c2c3102e7bc (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0391f182-1958-9fef-a944-53b229ce99e7 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution PROVIGIL has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d4c6858-5b2f-f216-e063-6394a90aad5d (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil tablets have an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63604fef-0b80-40ce-8dbf-3384f1aee395 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd1454b3-8599-4dfa-aaf7-b8a3ebe85acd (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil tablets has an apparent volume of distribution of approximately 0.9 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:928a3ab6-b53c-4924-882c-9f2f49aba0f1 (opens source in a new tab)
Modafinil label
Version not recorded · Effective date not recorded
Distribution Modafinil has an apparent volume of distribution of approximately 0.9 L/kg.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=1020Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.